February 17, 2026
TOPLINE: Daily 10-mg dapagliflozin treatment for 12 months was associated with a significant reduction in liver fat in patients with type 2 diabetes (T2D), independent of […]
February 17, 2026
Prebiotics and probiotics have been incorporated into clinical practice with a degree of ease that contrasts with the complexity of the evidence supporting their use. Part […]
February 17, 2026
Constipation is one of the most common gastrointestinal (GI) adverse effects associated with GLP-1s. Although typically characterized as mild-to-moderate, constipation remains a frequent contributor to treatment […]
February 16, 2026
Time-restricted feeding (TRF) significantly reduces symptomatic disease activity and systemic inflammation in adults with Crohn’s disease and overweight or obesity, according to new research. In a […]
February 13, 2026
TOPLINE: Revisional bariatric surgery procedures were associated with significantly higher odds of severe complications than primary procedures. METHODOLOGY: Researchers conducted an observational study in France between […]
February 13, 2026
TOPLINE: Among 12,245 patients with Crohn’s disease treated with advanced therapies, no significant differences were found in the risks for serious infections, venous thromboembolism, or major […]
February 11, 2026
Throughout most of her life, Katie Neu, a 31-year-old Massachusetts resident with Crohn’s disease, has struggled with insurance barriers. Diagnosed at age 10, Neu was initially […]
February 11, 2026
The Italian Association for the Study of the Liver (AISF) has published a position paper in the journal Digestive and Liver Disease addressing several unmet needs […]
July 4, 2025
TOPLINE: Patients with sludge- or microlithiasis-induced acute pancreatitis (AP) had significantly lower rates of pancreaticobiliary complications than those with gallstone-induced AP. METHODOLOGY: Researchers enrolled 789 patients […]